Pallas Capital Advisors LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,108 shares of the financial services provider's stock, valued at approximately $1,633,000.
A number of other hedge funds also recently modified their holdings of the business. Hunter Associates Investment Management LLC raised its holdings in shares of CME Group by 6.3% during the third quarter. Hunter Associates Investment Management LLC now owns 1,094 shares of the financial services provider's stock valued at $242,000 after purchasing an additional 65 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of CME Group by 10.1% during the third quarter. Nisa Investment Advisors LLC now owns 112,259 shares of the financial services provider's stock valued at $24,770,000 after purchasing an additional 10,302 shares during the period. Pullen Investment Management LLC raised its holdings in shares of CME Group by 1.8% during the third quarter. Pullen Investment Management LLC now owns 7,229 shares of the financial services provider's stock valued at $1,595,000 after purchasing an additional 128 shares during the period. Capital Advisors Ltd. LLC increased its position in shares of CME Group by 4.9% during the third quarter. Capital Advisors Ltd. LLC now owns 1,251 shares of the financial services provider's stock worth $276,000 after acquiring an additional 58 shares in the last quarter. Finally, Hamlin Capital Management LLC increased its position in shares of CME Group by 16.2% during the third quarter. Hamlin Capital Management LLC now owns 744,690 shares of the financial services provider's stock worth $164,316,000 after acquiring an additional 103,959 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Insider Transactions at CME Group
In other news, CFO Lynne Fitzpatrick sold 754 shares of the company's stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company's stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock valued at $3,351,895 in the last ninety days. Corporate insiders own 0.30% of the company's stock.
CME Group Trading Up 0.1 %
Shares of CME stock traded up $0.17 during trading hours on Wednesday, reaching $227.26. The company's stock had a trading volume of 1,211,270 shares, compared to its average volume of 1,921,584. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $81.83 billion, a P/E ratio of 25.85, a P/E/G ratio of 7.76 and a beta of 0.55. The firm's fifty day simple moving average is $220.05 and its 200 day simple moving average is $209.23. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 EPS. CME Group's quarterly revenue was up 18.4% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.04 EPS for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.02%. CME Group's payout ratio is 52.33%.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. Morgan Stanley boosted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 17th. The Goldman Sachs Group increased their target price on shares of CME Group from $195.00 to $198.00 and gave the company a "sell" rating in a research report on Thursday, October 3rd. Bank of America upped their price target on shares of CME Group from $177.00 to $180.00 and gave the company an "underperform" rating in a research note on Thursday, October 3rd. Barclays increased their price target on shares of CME Group from $219.00 to $231.00 and gave the stock an "equal weight" rating in a report on Thursday, October 24th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $222.73.
View Our Latest Analysis on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
